Fabino Life Sciences (BOM:543444) Debt-to-Revenue : 0.08 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Fabino Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Fabino Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹12.7 Mil. Fabino Life Sciences's annualized Revenue for the quarter that ended in Mar. 2024 was ₹164.4 Mil. Fabino Life Sciences's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.08.

Fabino Life Sciences Debt-to-Revenue Historical Data

The historical data trend for Fabino Life Sciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Debt-to-Revenue Chart

Fabino Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Revenue

Get a 7-Day Free Trial

0.14

0.10

0.01

0.12

0.06

Fabino Life Sciences Semi-Annual Data
	Mar19	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial			N/A	0.01	0.09	0.04	0.08

Competitive Comparison of Fabino Life Sciences's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fabino Life Sciences's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Debt-to-Revenue falls into.

Fabino Life Sciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Fabino Life Sciences's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	12.691)	/	210.828
	=	0.06

Fabino Life Sciences's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	12.691)	/	164.432
	=	0.08

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Mar. 2024) Revenue data.

Fabino Life Sciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fabino Life Sciences (BOM:543444) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001

Website

https://www.fabinolife.com

Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines